Renal Cell Carcinoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Study to Evaluate the Safety and Efficacy of Bicalutamide in Combination With Sunitinib in Patients With TKIs-resistant RCC
Conditions: Carcinoma, Renal Cell Interventions: Drug: Bicalutamide in combination with Sunitinib Sponsors: State University of New York at Buffalo Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 24, 2024 Category: Research Source Type: clinical trials

Proteomic Guided First-line Precision Treatment of Renal Clear Cell Carcinoma
Conditions: Kidney Cancer; Renal Cell Carcinoma; Renal Clear Cell Carcinoma Interventions: Drug: Anlotinib, Everolimus and Tislelizumab Sponsors: Fudan University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2024 Category: Research Source Type: clinical trials

Mechanisms of Somatic Mutation and Tumor Initiation in Pre-malignant Kidney Tubule Cells
Conditions: Renal Cell Cancer; Von Hippel-Lindau Disease Interventions: Other: Blood and urine sample collection Sponsors: IRCCS San Raffaele; Universit à Vita-Salute San Raffaele Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 8, 2024 Category: Research Source Type: clinical trials

Overtaking Intra and Inter Tumoral Heterogeneity In Von Hippel-Lindau Related Renal Cancer
Conditions: Clear Cell Renal Cell Carcinoma; VHL Syndrome Interventions: Other: Blood collection Sponsors: IRCCS San Raffaele Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 8, 2024 Category: Research Source Type: clinical trials

Study of Zanzalintinib (XL092) + AB521 and Zanzalintinib + AB521 + Nivolumab in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Other Advanced Solid Tumors (STELLAR-009)
Conditions: Advanced Clear Cell Renal Cell Carcinoma or Other Advanced Solid Tumors Interventions: Drug: zanzalintinib; Drug: AB521; Biological: Nivolumab Sponsors: Exelixis; Arcus Biosciences, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials

CD70-targeted CAR-NKT Cells(CGC729) Therapy in the Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma Interventions: Combination Product: Cyclophosphamide + Fludarabine + Infusion of CAR-NKT Cells Sponsors: Fudan University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 27, 2023 Category: Research Source Type: clinical trials

Head-to-head Comparison of Positron Nuclide Radio-labeled FAPI and 18F-FDG PET/CT in Patients With Malignant Tumors
Conditions: Renal Cell Carcinoma; Gastric Cancer; Hepatocellular Carcinoma; Signet Ring Cell Carcinoma; Mucinous Adenocarcinoma; Colorectal Cancer Interventions: Diagnostic Test: FAPI PET/CT Sponsors: Guangdong Provincial People ' s Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 27, 2023 Category: Research Source Type: clinical trials

Pilot Study of the eHealth Application " Cancer Patients Better Life Experience " (CAPABLE) - Italy
Conditions: Renal Cell Carcinoma Metastatic; Breast Cancer; Head and Neck Cancer; Thyroid Cancer; Ovary Cancer; Lung Cancer; Stomach Cancer Interventions: Device: CAPABLE cohort Sponsors: Istituti Clinici Scientifici Maugeri SpA; University of Pavia; Policlinico di Bari Ospedale Giovanni Paolo XXIII; Biomeris srl; The Netherlands Cancer Institute NKI; University of Haifa; Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); IBM Research; Bitsens JSC; Pozna ń University of Technology; Deontics LTD; Associazione Italiana Malati di Cancro AIMAC; Universidad Politécnica de Madrid. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2023 Category: Research Source Type: clinical trials

Multi-classifier System for Straitifying Stage III Papillary Renal Cell Carcinoma of Receiving Adjuvant Therapy
Conditions: Papillary Renal Cell Carcinoma Interventions: Drug: Pembrolizumab; Drug: Placebo Sponsors: First Affiliated Hospital, Sun Yat-Sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2023 Category: Research Source Type: clinical trials

Multi-classifier System for Stratifying Stage III Papillary Renal Cell Carcinoma of Receiving Adjuvant Therapy
Conditions: Papillary Renal Cell Carcinoma Interventions: Drug: Pembrolizumab; Drug: Placebo Sponsors: First Affiliated Hospital, Sun Yat-Sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2023 Category: Research Source Type: clinical trials

Cadonilimab Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC
Conditions: Cadonilimab; Clear Cell Renal Cell Carcinoma; Neoadjuvant Therapy Interventions: Drug: Cadonilimab Combined With Lenvatinib Sponsors: Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2023 Category: Research Source Type: clinical trials

Low Pressure Versus Standard Pressure Pneumoperitoneum in Laparoscopic Nephrectomy
Conditions: Non-Functioning Kidney; Renal Cell Carcinoma Interventions: Procedure: Laparoscopic Surgery Sponsors: Institute of medicine, Maharagjung medical campus Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials

A Study of Cabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the Brain
Conditions: Metastatic Renal Cell Carcinoma; Brain Metastases Interventions: Drug: Cabozantinib; Device: Nivolumab; Radiation: Stereotactic Radiosurgery (SRS) Sponsors: Memorial Sloan Kettering Cancer Center; Exelixis Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2023 Category: Research Source Type: clinical trials

Pucotenlimab Combined With Lenvatinib as a Neodjuvant Therapy for Non Clear Cell Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma Interventions: Drug: Pucotenlimab Combined With Lenvatinib Sponsors: Sun Yat-sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2023 Category: Research Source Type: clinical trials

Study of ST-1898 in Advanced Renal Cell Carcinoma
Conditions: Advanced Renal Cell Carcinoma Interventions: Drug: ST-1898 tablets Sponsors: Beijing Scitech-Mq Pharmaceuticals Limited Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2023 Category: Research Source Type: clinical trials